$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Pathogenesis of Gallstones

Gastroenterology clinics of North America, v.39 no.2, 2010년, pp.171 - 183  

Venneman, Niels Gerard ,  van Erpecum, Karel Johannes

Abstract AI-Helper 아이콘AI-Helper

Cholesterol gallstone formation is a complex process and involves phase separation of cholesterol crystals from supersaturated bile. In most cases, cholesterol hypersecretion is considered the primary event in gallstone formation. The sterol is transported through the hepatocytic canalicular membran...

참고문헌 (73)

  1. J Lipid Res Somjen 26 699 1985 10.1016/S0022-2275(20)34326-1 Contribution of vesicular and micellar carriers to cholesterol transport in human bile 

  2. Gastroenterology Halpern 90 875 1986 10.1016/0016-5085(86)90863-2 Rapid vesicle formation and aggregation in abnormal human biles: a time-lapse video-enhanced contrast microscopy study 

  3. Gastroenterology Holan 77 611 1979 10.1016/0016-5085(79)90209-9 Nucleation time: a key factor in the pathogenesis of cholesterol gallstone disease 

  4. J Lipid Res Wang 37 2539 1996 10.1016/S0022-2275(20)37458-7 Characterization of crystallization pathways during cholesterol precipitation from human gallbladder bile: identical pathways to corresponding model biles with three predominating sequences 

  5. J Lipid Res Wang 37 606 1996 10.1016/S0022-2275(20)37603-3 

  6. Biochim Biophys Acta Venneman 1686 3 209 2005 10.1016/j.bbalip.2004.10.004 Effects of hydrophobic and hydrophilic bile salts on gallstone growth and dissolution in model biles 

  7. Biochim Biophys Acta van Erpecum 1345 269 1997 10.1016/S0005-2760(97)00002-7 Influence of bile salts on molecular interactions between sphingomyelin and cholesterol: relevance to bile formation and stability 

  8. Hepatology van Erpecum 11 1 1990 10.1002/hep.1840110102 Bile concentration is a key factor for nucleation of cholesterol crystals and cholesterol saturation index in gallbladder bile of gallstone patients 

  9. Biol Cell van Erpecum 97 11 815 2005 10.1042/BC20040088 Biliary lipids, water and cholesterol gallstones 

  10. Hepatology Hussaini 22 1735 1995 Deoxycholic acid influences cholesterol solubilization and microcrystal nucleation time in gallbladder bile 

  11. Gastroenterology Thomas 119 3 806 2000 10.1053/gast.2000.16495 Mechanism for the transit-induced increase in colonic deoxycholic acid formation in cholesterol cholelithiasis 

  12. J Lipid Res Wang 38 1395 1997 10.1016/S0022-2275(20)37422-8 Phenotypic characterization of Lith genes that determine susceptibility to cholesterol cholelithiasis in inbred mice: physical-chemistry of gallbladder bile 

  13. J Lipid Res Hay 34 759 1993 10.1016/S0022-2275(20)39696-6 Molecular species of lecithins in human gallbladder bile 

  14. J Biol Chem Harvey 266 13996 1991 10.1016/S0021-9258(18)92801-2 Immunoglobulins as nucleating proteins in the gallbladder bile of patients with cholesterol gallstones 

  15. J Lipid Res Abei 34 1141 1993 10.1016/S0022-2275(20)37701-4 Cholesterol crystallization-promoters in human bile: comparative potencies of immunoglobulins, α1-acid glycoprotein, phospholipase C, and aminopeptidase N 

  16. J Lipid Res Yamashita 36 1325 1995 10.1016/S0022-2275(20)41140-X Biliary haptoglobin, a potent promoter of cholesterol crystallization at physiological concentrations 

  17. Gastroenterology Abei 106 231 1994 10.1016/S0016-5085(94)95643-X Identification of human biliary α1-acid glycoprotein as a cholesterol crystallization promotor 

  18. Dig Dis Sci Nuutinen 40 1174 1995 10.1007/BF02065520 Correlation between biliary α1-acid glycoprotein concentration and cholesterol crystal nucleation time in gallstone disease 

  19. Gastroenterology Offner 106 755 1994 10.1016/0016-5085(94)90712-9 Identification of a 130-kilodalton human biliary concanavalin A binding protein as aminopeptidase N 

  20. J Clin Invest Lee 67 1712 1981 10.1172/JCI110209 Role of gallbladder mucus hypersecretion in the evolution of cholesterol gallstones. Studies in the prairie dog 

  21. Science Kibe 255 514 1984 10.1126/science.6429856 Inhibition of cholesterol crystal formation by apolipoproteins in supersaturated model bile 

  22. Gastroenterology Busch 115 129 1998 10.1016/S0016-5085(98)70374-9 Biliary secretory immunoglobulin A is a major constituent of the new group of cholesterol crystal-binding proteins 

  23. Gastroenterology Miquel 114 1016 1998 10.1016/S0016-5085(98)70322-1 Cholesterol saturation, not proteins or cholecystitis, is critical for crystal formation in human gallbladder bile 

  24. J Lipid Res Wang 40 415 1999 10.1016/S0022-2275(20)32445-7 No pathophysiologic relationship of soluble biliary proteins to cholesterol crystallization in human bile 

  25. J Hepatol van Erpecum 35 444 2001 10.1016/S0168-8278(01)00173-8 Phenotypic characterization of Lith genes that determine susceptibility to cholesterol cholelithiasis in inbred mice: soluble pronucleating proteins in gallbladder and hepatic biles 

  26. Hepatology Smith 12 183S 1990 Gallbladder mucin as a pronucleating agent for cholesterol monohydrate crystals in bile 

  27. Gastroenterology Lammert 120 221 2001 10.1053/gast.2001.20878 Chromosomal organization of candidate genes involved in cholesterol gallstone formation: a murine gallstone map 

  28. Hepatology Lammert 36 5 1145 2002 10.1053/jhep.2002.36821 Lith genes control mucin accumulation, cholesterol crystallization, and gallstone formation in A/J and AKR/J inbred mice 

  29. Science Lee 211 1429 1981 10.1126/science.7466399 Aspirin prevention of cholesterol gallstone formation in prairie dogs 

  30. Lancet Hood 2 1223 1988 10.1016/S0140-6736(88)90812-4 Prevention of gallstone recurrence by non-steroidal anti- inflammatory drugs 

  31. Gastroenterology van Erpecum 110 1225 1996 10.1053/gast.1996.v110.pm8613013 Ursodeoxycholic acid reduces protein levels and nucleation-promoting activity in human gallbladder bile 

  32. J Hepatol van Erpecum 14 194 1992 10.1016/0168-8278(92)90158-L Fasting gallbladder volume, postprandial emptying and cholecystokinin release in gallstone patients and normal subjects 

  33. Gastroenterology Pauletzki 111 765 1996 10.1053/gast.1996.v111.pm8780583 Gallbladder emptying and gallstone formation: a prospective study on gallstone recurrence 

  34. Am J Physiol Stolk 264 G596 1993 Motor cycles with phase III in antrum are associated with high motilin levels and prolonged gallbladder emptying 

  35. Dig Dis Sci Stolk 46 6 1328 2001 10.1023/A:1010635901414 Interdigestive gallbladder emptying, antroduodenal motility, and motilin release patterns are altered in cholesterol gallstone patients 

  36. Gastroenterology Xu 112 A1417 1997 Altered migrating myoelectrical complex (MMC) in an animal model of cholesterol gallstone disease 

  37. Gastroenterology Corradini 118 5 912 2000 10.1016/S0016-5085(00)70177-6 Impaired human gallbladder lipid absorption in cholesterol gallstone disease and its effect on cholesterol solubility in bile 

  38. Hepatology Corradini 28 314 1998 10.1002/hep.510280205 The human gallbladder increases cholesterol solubility in bile by differential lipid absorption: a study using a new in vitro model of isolated intra-arterially perfused gallbladder 

  39. Gastroenterology Yu 108 A442 1995 10.1016/0016-5085(95)26083-8 Excess membrane cholesterol impairs gallbladder muscle contraction 

  40. J Lipid Res van Erpecum 47 1 32 2006 10.1194/jlr.M500180-JLR200 Gallbladder histopathology during murine gallstone formation: relation to motility and concentrating function 

  41. Gastroenterology Maurer 136 2 425 2009 10.1053/j.gastro.2008.12.031 Roles of infection, inflammation, and the immune system in cholesterol gallstone formation 

  42. Gastroenterology Galman 126 3 741 2004 10.1053/j.gastro.2003.12.009 Bile acid synthesis is increased in Chilean Hispanics with gallstones and in gallstone high-risk Mapuche Indians 

  43. J Lipid Res Bergheim 47 1 42 2006 10.1194/jlr.M500215-JLR200 Apical sodium bile acid transporter and ileal lipid binding protein in gallstone carriers 

  44. J Lipid Res Renner 49 9 2045 2008 10.1194/jlr.M800162-JLR200 Reduced ileal expression of OSTalpha-OSTbeta in non-obese gallstone disease 

  45. J Clin Invest Kern 93 1186 1994 10.1172/JCI117072 Effects of dietary cholesterol on cholesterol and bile acids homeostasis in patients with cholesterol gallstones 

  46. Biochem Biophys Res Commun Jiang 379 1 49 2009 10.1016/j.bbrc.2008.11.131 Increased NPC1L1 and ACAT2 expression in the jejunal mucosa from Chinese gallstone patients 

  47. Gastroenterology Wang 134 7 2101 2008 10.1053/j.gastro.2008.03.011 Effect of ezetimibe on the prevention and dissolution of cholesterol gallstones 

  48. J Lipid Res Wang 50 Suppl S406 2009 10.1194/jlr.R800075-JLR200 Biliary lipids and cholesterol gallstone disease 

  49. Proc Natl Acad Sci U S A Yu 99 25 16237 2002 10.1073/pnas.252582399 Disruption of Abcg5 and Abcg8 in mice reveals their crucial role in biliary cholesterol secretion 

  50. Nat Genet Buch 39 8 995 2007 10.1038/ng2101 A genome-wide association scan identifies the hepatic cholesterol transporter ABCG8 as a susceptibility factor for human gallstone disease 

  51. Hepatology Grunhage 46 3 793 2007 10.1002/hep.21847 Increased gallstone risk in humans conferred by common variant of hepatic ATP-binding cassette transporter for cholesterol 

  52. Science Berge 290 5497 1771 2000 10.1126/science.290.5497.1771 Accumulation of dietary cholesterol in sitosterolemia caused by mutations in adjacent ABC transporters 

  53. J Biol Chem Gerloff 273 10046 1998 10.1074/jbc.273.16.10046 The sister of P-glycoprotein represents the canalicular bile salt export pump of mammalian liver 

  54. Gastroenterology van Mil 127 2 379 2004 10.1053/j.gastro.2004.04.065 Benign recurrent intrahepatic cholestasis type 2 is caused by mutations in ABCB11 

  55. Cell Smit 75 451 1993 10.1016/0092-8674(93)90380-9 Homozygous disruption of the murine mdr2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver disease 

  56. Gastroenterology Rosmorduc 125 2 452 2003 10.1016/S0016-5085(03)00898-9 ABCB4 gene mutation-associated cholelithiasis in adults 

  57. Cell Mangelsdorf 83 6 835 1995 10.1016/0092-8674(95)90199-X The nuclear receptor superfamily: the second decade 

  58. J Biol Chem Lu 276 41 37735 2001 10.1074/jbc.R100035200 Orphan nuclear receptors as eLiXiRs and FiXeRs of sterol metabolism 

  59. Science Makishima 284 5418 1362 1999 10.1126/science.284.5418.1362 Identification of a nuclear receptor for bile acids 

  60. Mol Cell Lu 6 3 507 2000 10.1016/S1097-2765(00)00050-2 Molecular basis for feedback regulation of bile acid synthesis by nuclear receptors 

  61. Nat Med Moschetta 10 12 1352 2004 10.1038/nm1138 Prevention of cholesterol gallstone disease by FXR agonists in a mouse model 

  62. J Hepatol Kovacs 48 1 116 2008 10.1016/j.jhep.2007.07.027 Variation of the gene encoding the nuclear bile salt receptor FXR and gallstone susceptibility in mice and humans 

  63. Hepatology Uppal 47 4 1331 2008 10.1002/hep.22175 Activation of liver X receptor sensitizes mice to gallbladder cholesterol crystallization 

  64. J Lipid Res Jiang 49 2 464 2008 10.1194/jlr.M700295-JLR200 Increased expression of LXR alpha, ABCG5, ABCG8, and SR-BI in the liver from normolipidemic, nonobese Chinese gallstone patients 

  65. Scand J Gastroenterol van Erpecum 23 948 1988 10.3109/00365528809090152 Cholesterol and pigment gallstone disease: comparison of the reliability of three bile tests for differentiation between the two stone types 

  66. Blood Haverfield 105 3 968 2005 10.1182/blood-2004-02-0521 UGT1A1 variation and gallstone formation in sickle cell disease 

  67. Gastroenterology Brink 110 6 1945 1996 10.1053/gast.1996.v110.pm8964422 Bilirubin cycles enterohepatically after ileal resection in the rat 

  68. Gastroenterology Mendez-Sanchez 115 3 722 1998 10.1016/S0016-5085(98)70152-0 Ursodeoxycholic acid and cholesterol induce enterohepatic cycling of bilirubin in rodents 

  69. Gastroenterology Brink 116 6 1420 1999 10.1016/S0016-5085(99)70507-X Enterohepatic cycling of bilirubin: a putative mechanism for pigment gallstone formation in ileal Crohn's disease 

  70. Am J Physiol Gastrointest Liver Physiol Freudenberg 294 6 G1411 2008 10.1152/ajpgi.00181.2007 Pathophysiological basis of liver disease in cystic fibrosis employing a DeltaF508 mouse model 

  71. Hepatology Wasmuth 43 4 738 2006 10.1002/hep.21105 Coinheritance of Gilbert syndrome-associated UGT1A1 mutation increases gallstone risk in cystic fibrosis 

  72. Gastroenterology Gleeson 102 1707 1992 10.1016/0016-5085(92)91734-L Calcium and carbonate ion concentrations in gallbladder and hepatic bile 

  73. Surg Clin North Am Lambou-Gianoukos 88 6 1175 2008 10.1016/j.suc.2008.07.009 Lithogenesis and bile metabolism 

관련 콘텐츠

저작권 관리 안내
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로